EU-Startups
€99 million Series D fuels Artios’ expansion of precision cancer treatment pipeline
Artios Pharma Limited, a British biopharmaceutical company committed to realising the therapeutic potential of targeting the DNA damage response (DDR) in cancer, today announced the successful […]
